Panel Discussion: Pharma’s Perspective on Search & Discovery in Pain Therapeutics
- What is the industry looking for in terms of novel pain therapies?
- Target prioritization for pharma between NaV channels and emerging novel targets
- The importance of having pre-clinical data beyond animal studies to validate novel pain targets
- Utilizing human biology data sets to help determine the translational potential